FASLODEX
FASLODEX
Approved
DIN Number
02248624
Drug Class
Human
Market Date
Jun 14, 2004
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02248624
AIG Number0149744001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BA03 FULVESTRANT
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FULVESTRANTActive
Strength: 50 MG / ML
Monograph: FULVESTRANT